Scarica l'app Stockscreener
0.9404
5.96%
-0.0596
Dopo l'orario di chiusura:
.96
0.0196
+2.08%
Precedente Chiudi:
$1.00
Aprire:
$1
Volume 24 ore:
138.88K
Relative Volume:
0.61
Capitalizzazione di mercato:
$44.50M
Reddito:
$10.85M
Utile/perdita netta:
$-51.31M
Rapporto P/E:
-1.276
EPS:
-0.737
Flusso di cassa netto:
$-36.77M
1 W Prestazione:
-5.96%
1M Prestazione:
-24.77%
6M Prestazione:
-55.00%
1 anno Prestazione:
-62.83%
Intervallo 1D:
$0.9201
$1.00
Intervallo di 1 settimana:
$0.9201
$1.05
Portata 52W:
$0.9201
$2.9319
InspireMD Inc. Stock (NSPR) Company Profile
Nome
InspireMD Inc.
Settore
Industria
Telefono
972 3 6917691
Indirizzo
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
0.95 | 46.84M | 10.85M | -51.31M | -36.77M | -0.737 |
ABT
Abbott Laboratories
|
86.66 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.95 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.59 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.66 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.56 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-02 | Iniziato | Maxim Group | Buy |
| 2016-01-07 | Iniziato | Rodman & Renshaw | Buy |
| 2015-03-13 | Downgrade | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Iniziato | Oppenheimer | Outperform |
InspireMD Inc. Borsa (NSPR) Ultime notizie
InspireMD (NSPR) Q1 2026 Earnings: EPS Beat Despite Net Loss, Shares Dip 2.9%Post-Announcement Reaction - Newser
Paul Stuka to Retire from InspireMD Board, Will Not Seek Re‑election - TradingView
InspireMD (NSPR) chair Paul Stuka plans Board retirement in 2027 - Stock Titan
NSPR Technical Analysis | Trend, Signals & Chart Patterns | INSPIREMD INC (NASDAQ:NSPR) - ChartMill
NSPR Q1 2026 Earnings: Loss Narrower Than Expected as InspireMD Advances Commercial PipelineProfit Growth Outlook - Newser
InspireMD CCO Shane Gleason sells $189,594 in stock By Investing.com - Investing.com Australia
InspireMD CCO Shane Gleason sells $189,594 in stock - Investing.com
InspireMD (NSPR) CCO auto-sells shares to cover RSU tax obligations - Stock Titan
InspireMD (NSPR) price target decreased by 13.33% to 4.42 - MSN
Nantahala reports 4.82M shares in InspireMD (NSPR) including convertibles - Stock Titan
Director Stuka increases InspireMD (NSPR) stake with 15,000-share buys - Stock Titan
Velan Capital holds 4.99% of InspireMD (NASDAQ: NSPR) via 2.35M shares - Stock Titan
NSPR Stock Price, Quote & Chart | INSPIREMD INC (NASDAQ:NSPR) - ChartMill
InspireMD CEO Marvin Slosman buys $25,200 in company stock By Investing.com - Investing.com Australia
InspireMD Inc (NSPR) CEO Marvin Slosman Increases Stake with Rec - GuruFocus
NSPR: Endovascular stenting for carotid disease is accelerating, backed by best-in-class clinical results - TradingView
InspireMD CEO Marvin Slosman buys $25,200 in company stock - Investing.com UK
InspireMD (NSPR) CEO adds 21,000 shares in $1.20 open-market buy - Stock Titan
InspireMD (NSPR) director boosts stake with 75,626-share buy, corrects 10b5-1 and ownership details - Stock Titan
InspireMD director Paul Stuka buys $88,026 in shares - Investing.com UK
InspireMD director Paul Stuka buys $88,026 in shares By Investing.com - Investing.com South Africa
InspireMD (NSPR) director Paul Stuka adds 75,626 shares in open-market buys - Stock Titan
InspireMD Balances Fast Growth With U.S. Setback - TipRanks
MSN Money - MSN
InspireMD (NSPR) Q2 2025 Earnings Transcript - AOL.com
InspireMD (NSPR) Q3 2025 Earnings Transcript - AOL.com
Insider Buying: InspireMD (NYSE:NSPR) Director Acquires 15,995 Shares of Stock - MarketBeat
Insider Buying: InspireMD (NYSE:NSPR) Director Acquires 73,255 Shares of Stock - MarketBeat
InspireMD director Ward R. buys $102,637 in company stock By Investing.com - Investing.com Australia
InspireMD director Ward R. buys $102,637 in company stock - Investing.com India
InspireMD director Gary Roubin buys $106,200 in company stock - Investing.com UK
[Form 4] InspireMD, Inc. Insider Trading Activity - Stock Titan
InspireMD director Gary Roubin buys $106,200 in company stock By Investing.com - Investing.com Nigeria
Gary Roubin Buys 90,000 Shares of InspireMD (NYSE:NSPR) Stock - MarketBeat
Director Paul Stuka adds 7,895 InspireMD (NSPR) shares in open‑market buys - Stock Titan
Why InspireMD (NSPR) ability to execute stands out (Underperforming) 2026-05-08Long Setup - newser.com
What InspireMD (NSPR) is doing to win in its industry | Q1 2026: Earnings Beat EstimatesManagement Guidance Update - Newser
InspireMD Inc. Azioni (NSPR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.35%
2.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):